All thresholds of maternal hyperglycaemia from the WHO 2013 criteria for gestational diabetes identify women with a higher genetic risk for type 2 diabetes
Copyright: © 2020 Hughes AE et al..
Background: Using genetic scores for fasting plasma glucose (FPG GS) and type 2 diabetes (T2D GS), we investigated whether the fasting, 1-hour and 2-hour glucose thresholds from the WHO 2013 criteria for gestational diabetes (GDM) have different implications for genetic susceptibility to raised fasting glucose and type 2 diabetes in women from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) and Atlantic Diabetes in Pregnancy (DIP) studies. Methods: Cases were divided into three subgroups: (i) FPG ≥5.1 mmol/L only, n=222; (ii) 1-hour glucose post 75 g oral glucose load ≥10 mmol/L only, n=154 (iii) 2-hour glucose ≥8.5 mmol/L only, n=73; and (iv) both FPG ≥5.1 mmol/L and either of a 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, n=172. We compared the FPG and T2D GS of these groups with controls (n=3,091) in HAPO and DIP separately. Results: In HAPO and DIP, the mean FPG GS in women with a FPG ≥5.1 mmol/L, either on its own or with 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, was higher than controls (all P <0.01). Mean T2D GS in women with a raised FPG alone or with either a raised 1-hour or 2-hour glucose was higher than controls (all P <0.05). GDM defined by 1-hour or 2-hour hyperglycaemia only was also associated with a higher T2D GS than controls (all P <0.05). Conclusions: The different diagnostic categories that are part of the WHO 2013 criteria for GDM identify women with a genetic predisposition to type 2 diabetes as well as a risk for adverse pregnancy outcomes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
---|---|
Enthalten in: |
Wellcome open research - 5(2020) vom: 18., Seite 175 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hughes, Alice E [VerfasserIn] |
---|
Links: |
---|
Themen: |
Fasting plasma glucose |
---|
Anmerkungen: |
Date Revised 22.04.2021 published: Electronic-eCollection figshare: 10.6084/m9.figshare.14180033 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.12688/wellcomeopenres.16097.2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM324244622 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM324244622 | ||
003 | DE-627 | ||
005 | 20240401232007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12688/wellcomeopenres.16097.2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1359.xml |
035 | |a (DE-627)NLM324244622 | ||
035 | |a (NLM)33869792 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hughes, Alice E |e verfasserin |4 aut | |
245 | 1 | 0 | |a All thresholds of maternal hyperglycaemia from the WHO 2013 criteria for gestational diabetes identify women with a higher genetic risk for type 2 diabetes |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.04.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a figshare: 10.6084/m9.figshare.14180033 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright: © 2020 Hughes AE et al. | ||
520 | |a Background: Using genetic scores for fasting plasma glucose (FPG GS) and type 2 diabetes (T2D GS), we investigated whether the fasting, 1-hour and 2-hour glucose thresholds from the WHO 2013 criteria for gestational diabetes (GDM) have different implications for genetic susceptibility to raised fasting glucose and type 2 diabetes in women from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) and Atlantic Diabetes in Pregnancy (DIP) studies. Methods: Cases were divided into three subgroups: (i) FPG ≥5.1 mmol/L only, n=222; (ii) 1-hour glucose post 75 g oral glucose load ≥10 mmol/L only, n=154 (iii) 2-hour glucose ≥8.5 mmol/L only, n=73; and (iv) both FPG ≥5.1 mmol/L and either of a 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, n=172. We compared the FPG and T2D GS of these groups with controls (n=3,091) in HAPO and DIP separately. Results: In HAPO and DIP, the mean FPG GS in women with a FPG ≥5.1 mmol/L, either on its own or with 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, was higher than controls (all P <0.01). Mean T2D GS in women with a raised FPG alone or with either a raised 1-hour or 2-hour glucose was higher than controls (all P <0.05). GDM defined by 1-hour or 2-hour hyperglycaemia only was also associated with a higher T2D GS than controls (all P <0.05). Conclusions: The different diagnostic categories that are part of the WHO 2013 criteria for GDM identify women with a genetic predisposition to type 2 diabetes as well as a risk for adverse pregnancy outcomes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Gestational diabetes | |
650 | 4 | |a fasting plasma glucose | |
650 | 4 | |a genetic scores | |
650 | 4 | |a type 2 diabetes | |
700 | 1 | |a Hayes, M Geoffrey |e verfasserin |4 aut | |
700 | 1 | |a Egan, Aoife M |e verfasserin |4 aut | |
700 | 1 | |a Patel, Kashyap A |e verfasserin |4 aut | |
700 | 1 | |a Scholtens, Denise M |e verfasserin |4 aut | |
700 | 1 | |a Lowe, Lynn P |e verfasserin |4 aut | |
700 | 1 | |a Lowe, William L |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Dunne, Fidelma P |e verfasserin |4 aut | |
700 | 1 | |a Hattersley, Andrew T |e verfasserin |4 aut | |
700 | 1 | |a Freathy, Rachel M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Wellcome open research |d 2016 |g 5(2020) vom: 18., Seite 175 |w (DE-627)NLM266828248 |x 2398-502X |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2020 |g day:18 |g pages:175 |
856 | 4 | 0 | |u http://dx.doi.org/10.12688/wellcomeopenres.16097.2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 5 |j 2020 |b 18 |h 175 |